DTP-HepB-IPV-Hib vaccine - LG Chem

Drug Profile

DTP-HepB-IPV-Hib vaccine - LG Chem

Alternative Names: Diphtheria-Tetanus-Pertussis-Hepatitis B-Inactivated Poliovirus-Haemophilus influenzae type b vaccine

Latest Information Update: 14 Jul 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator LG Chem
  • Class Bacterial vaccines; Haemophilus vaccines; Hepatitis B vaccines; Viral hepatitis vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus

Most Recent Events

  • 03 Jul 2017 Phase-I clinical trials in Diphtheria (Prevention, In volunteers) in South Korea (Parenteral) (NCT03208101)
  • 03 Jul 2017 Phase-I clinical trials in Haemophilus infections (Prevention, In volunteers) in South Korea (Parenteral) (NCT03208101)
  • 03 Jul 2017 Phase-I clinical trials in Hepatitis B (Prevention, In volunteers) in South Korea (Parenteral) (NCT03208101)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top